Tackling COVID‐19 Using Remdesivir and Favipiravir as Therapeutic Options
-
- Obireddy Sreekanth Reddy
- Department of Chemistry Sri Sri Krishnadevaraya University Anantapur 515003 India
-
- Wing‐Fu Lai
- Ciechanover Institute of Precision and Regenerative Medicine, School of Life and Health Sciences The Chinese University of Hong Kong (Shenzhen) Shenzhen 518172 P. R. China
説明
<jats:title>Abstract</jats:title><jats:p>The human world is currently influenced largely by the outbreak of pandemic COVID‐19. At this moment, most researchers focus on developing treatment strategies and measures to work against COVID‐19. Treatment strategies specific for COVID‐19 are lacking. This article provides an overview of the life cycle and routes of transmission of SARS‐CoV‐2. The therapeutic effects of two drugs [i. e., remdesivir (RDV) and favipiravir (FPV)] which can potentially tackle COVID‐19 are discussed based on current published data. This review can serve as a reference for future studies.</jats:p>
収録刊行物
-
- ChemBioChem
-
ChemBioChem 22 (6), 939-948, 2020-11-11
Wiley
